The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological ...

For Israel to properly understand its security needs and future risks, it is also important to come to a dispassionate and apolitical evaluation of the major issues involved in the US-Iran deal. There ...

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...

Subscribe! Want more math video lessons? Visit my website to view all of my math videos organized by course, chapter and section. The purpose of posting my free video tutorials is to not only help ...

According to the report, any operation would not involve a full-scale invasion but would instead focus on special operations missions and specific infantry ground operations. The report also mentions ...

At the outset of the U.S.-Israel-led war in Iran, President Trump gave lots of reasons for launching the strikes on Iran from stopping its nuclear capabilities to regime change. Now, Trump seems to be ...

The Israeli military said it had sent a broad wave of strikes at the Iranian capital early Saturday. Some strikes hit an area near the Mehrabad Airport. Footage shared on state media showed multiple ...

Iranian strikes on the U.A.E. were reported early Tuesday, the U.S. Embassy in Riyadh was hit by drones, and Israel said it was attacking Hezbollah targets in Lebanon. President Trump said the ...

We provide the 9 models evaluated in the MetaAligner paper as follows. Note that though all models are fine-tuned on certain objectives, you can always extend their capability to unseen objectives by ...

Objective: This study aimed to assessing dissatisfaction with allocation of health care resources from the perspective of patients with different diseases that can help optimize resource allocation ...

Beyond obesity, Novo Nordisk revealed this morning that its broader pipeline has suffered its own setbacks. (jhorrocks/iStock/Getty Images Plus) Novo Nordisk has abandoned another GLP-1/GIP co-agonist ...